Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Marinus Pharmaceuticals Inc shares valued at $864 were sold by Ezickson Elan on Jan 21 ’25. At $0.54 per share, Ezickson Elan sold 1,600 shares. The insider’s holdings dropped to 10,900 shares worth approximately $5886.0 following the completion of this transaction.
Also, Johnson Marvin sold 1,610 shares, netting a total of over 869 in proceeds. Following the sale of shares at $0.54 each, the insider now holds 12,490 shares.
Before that, Saraswathy Nochur had added 13,250 shares to its account. In a trade valued at $3,743, the Director bought Marinus Pharmaceuticals Inc shares for $0.28 each.
As published in a research note from Oppenheimer on September 23, 2024, Marinus Pharmaceuticals Inc [MRNS] has been rated up from a Perform to an Outperform and the price target has been revised to $6. Analysts at Ladenburg Thalmann downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in mid August. As of April 16, 2024, Robert W. Baird has decreased its “an Outperform” rating to a “Neutral” for MRNS. Earlier on April 15, 2024, RBC Capital Mkts downgraded its rating. Their new recommendation was “a Sector perform” for MRNS stock which previously was a “an Outperform”.
Analyzing MRNS Stock Performance
During the last five days, there has been a drop of approximately -0.41%. Over the course of the year, Marinus Pharmaceuticals Inc shares have jumped approximately 1.03%. Shares of the company reached a 52-week high of $0.5560 on 01/13/25 and a 52-week low of $0.5210 on 01/02/25. A 50-day SMA is recorded $0.3957, while a 200-day SMA reached $1.0932. Nevertheless, trading volume fell to 1.78 million shares from 0.25 million shares the previous day.
Support And Resistance Levels for Marinus Pharmaceuticals Inc (MRNS)
According to the 24-hour chart, there is a support level at 0.5392, which, if violated, would cause prices to drop to 0.5379. In the upper region, resistance lies at 0.5423. The next price resistance is at 0.5441. RSI (Relative Strength Index) is 68.46 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0010, which suggests the price will decrease in the coming days. Percent R is at 59.23%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
